Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak
Subject
Description
After the first pandemic wave in Europe, seroprevalence surveys revealed that roughly one in ten individuals had been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Date
2021-02-01
Type
Citation
Stringhini, Silvia, María-Eugenia Zaballa, Javier Perez-Saez, Nick Pullen, Carlos de Mestral, Attilio Picazio, Francesco Pennacchio, Ania Wisniak, Aude Richard, Helene Baysson, Andrea Loizeau, Jean-François Balavoine, Didier Trono, Didier Pittet, Klara Posfay-Barbe, Antoine Flahault, François Chappuis, Omar Kherad, Nicolas Vuilleumier, Laurent Kaiser, Andrew S. Azman, and Idris Guessous. 2021. "Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak." The Lancet Infectious Diseases.
Accessibility
Free online on Lancet site.
Was this resource helpful?